» Articles » PMID: 18805982

Modification of Pseudomonas Aeruginosa Pa5196 Type IV Pilins at Multiple Sites with D-Araf by a Novel GT-C Family Arabinosyltransferase, TfpW

Overview
Journal J Bacteriol
Specialty Microbiology
Date 2008 Sep 23
PMID 18805982
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa Pa5196 produces type IV pilins modified with unusual alpha1,5-linked d-arabinofuranose (alpha1,5-D-Araf) glycans, identical to those in the lipoarabinomannan and arabinogalactan cell wall polymers from Mycobacterium spp. In this work, we identify a second strain of P. aeruginosa, PA7, capable of expressing arabinosylated pilins and use a combination of site-directed mutagenesis, electrospray ionization mass spectrometry (MS), and electron transfer dissociation MS to identify the exact sites and extent of pilin modification in strain Pa5196. Unlike previously characterized type IV pilins that are glycosylated at a single position, those from strain Pa5196 were modified at multiple sites, with modifications of alphabeta-loop residues Thr64 and Thr66 being important for normal pilus assembly. Trisaccharides of alpha1,5-D-Araf were the principal modifications at Thr64 and Thr66, with additional mono- and disaccharides identified on Ser residues within the antiparallel beta sheet region of the pilin. TfpW was hypothesized to encode the pilin glycosyltransferase based on its genetic linkage to the pilin, weak similarity to membrane-bound GT-C family glycosyltransferases (which include the Mycobacterium arabinosyltransferases EmbA/B/C), and the presence of characteristic motifs. Loss of TfpW or mutation of key residues within the signature GT-C glycosyltransferase motif completely abrogated pilin glycosylation, confirming its involvement in this process. A Pa5196 pilA mutant complemented with other Pseudomonas pilins containing potential sites of modification expressed nonglycosylated pilins, showing that TfpW's pilin substrate specificity is restricted. TfpW is the prototype of a new type IV pilin posttranslational modification system and the first reported gram-negative member of the GT-C glycosyltransferase family.

Citing Articles

Structural conservation and functional role of TfpY-like proteins in type IV pilus assembly.

Qaderi I, Chan I, Harvey H, Burrows L J Bacteriol. 2025; 207(2):e0034324.

PMID: 39817748 PMC: 11841053. DOI: 10.1128/jb.00343-24.


The 1.3 Å resolution structure of the truncated group Ia type IV pilin from Pseudomonas aeruginosa strain P1.

Bragagnolo N, Audette G Acta Crystallogr D Struct Biol. 2024; 80(Pt 12):834-849.

PMID: 39607821 PMC: 11626772. DOI: 10.1107/S205979832401132X.


Spread of ST274 Clone in Different Niches: Resistome, Virulome, and Phylogenetic Relationship.

Chichon G, Lopez M, de Toro M, Ruiz-Roldan L, Rojo-Bezares B, Saenz Y Antibiotics (Basel). 2023; 12(11).

PMID: 37998763 PMC: 10668709. DOI: 10.3390/antibiotics12111561.


Sculpting the Bacterial -Glycoproteome: Functional Analyses of Orthologous Oligosaccharyltransferases with Diverse Targeting Specificities.

Hadjineophytou C, Anonsen J, Svingerud T, Mortimer T, Grad Y, Scott N mBio. 2022; 13(3):e0379721.

PMID: 35471082 PMC: 9239064. DOI: 10.1128/mbio.03797-21.


The Dynamic Structures of the Type IV Pilus.

McCallum M, Burrows L, Howell P Microbiol Spectr. 2019; 7(2).

PMID: 30825300 PMC: 11588161. DOI: 10.1128/microbiolspec.PSIB-0006-2018.


References
1.
Kikuchi N, Kwon Y, Gotoh M, Narimatsu H . Comparison of glycosyltransferase families using the profile hidden Markov model. Biochem Biophys Res Commun. 2003; 310(2):574-9. DOI: 10.1016/j.bbrc.2003.09.031. View

2.
Coleman F, Mueschenborn S, Meluleni G, Ray C, Carey V, Vargas S . Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc Natl Acad Sci U S A. 2003; 100(4):1949-54. PMC: 149939. DOI: 10.1073/pnas.0437901100. View

3.
Kus J, Tullis E, Cvitkovitch D, Burrows L . Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology (Reading). 2004; 150(Pt 5):1315-1326. DOI: 10.1099/mic.0.26822-0. View

4.
Syka J, Coon J, Schroeder M, Shabanowitz J, Hunt D . Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A. 2004; 101(26):9528-33. PMC: 470779. DOI: 10.1073/pnas.0402700101. View

5.
Hegge F, Hitchen P, Aas F, Kristiansen H, Lovold C, Egge-Jacobsen W . Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili. Proc Natl Acad Sci U S A. 2004; 101(29):10798-803. PMC: 490014. DOI: 10.1073/pnas.0402397101. View